NCT05462041View on ClinicalTrials.gov

DCD IIT: Evaluating the Safety of Utilizing Donor Hearts From Donation After Circulatory Death (DCD) Donors

NAActive, not recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 24, 2022

Primary Completion Date

August 31, 2024

Study Completion Date

December 31, 2025

Conditions
Organ Transplant
Interventions
OTHER

DBD Donor Heart Transplantation

A technique of donor heart procurement.

DEVICE

DCD Donor Heart Transplantation

A technique of donor heart procurement. The TransMedics' OCS Heart technology is the only portable system available for ex-vivo maintenance of the donor heart in a metabolically active and beating state. It is currently FDA approved for procurement and transport.

Trial Locations (1)

90048

Cedars Sinai Medical Center, Los Angeles

All Listed Sponsors
lead

Cedars-Sinai Medical Center

OTHER